Latest News about FDA
Recent news which mentions FDA
Spero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program
September 06, 2022
Tickers
SPRO
From Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
From Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
September 06, 2022
Tickers
EIGR
From Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
September 02, 2022
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
FDA Advisory Committee Meeting Scheduled For October 28, 2022 To Review Y-mAbs' Refiling For Omburtamab
September 01, 2022
Tickers
YMAB
From Benzinga
Intellia Gets FDA Orphan Drug Status For Hereditary Angioedema Candidate
September 01, 2022
Tickers
NTLA
From Benzinga
Amneal Seeks FDA Approval For Its Parkinson's Candidate
September 01, 2022
Tickers
AMRX
From Benzinga
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers
SNY
From Benzinga
From Benzinga
From Benzinga
Longeveron Shares Ascend As FDA Grants Fast Track Status To Congenital Heart Disease Candidate
August 31, 2022
Tickers
LGVN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.